As of 2024-12-12, the EV/EBITDA ratio of Codiak BioSciences, Inc. (CDAK) is 0.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CDAK's latest enterprise value is -21.30 mil USD. CDAK's TTM EBITDA according to its financial statements is -62.43 mil USD. Dividing these 2 quantities gives us the above CDAK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 16.6x - 24.3x | 18.5x |
| Forward P/E multiples | 17.8x - 26.0x | 25.2x |
| Fair Price | (13.00) - (17.85) | (15.99) |
| Upside | -22904.5% - -31412.4% | -28153.2% |
| Date | EV/EBITDA |